Literature DB >> 10920463

24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.

J A Posener1, C DeBattista, G H Williams, H Chmura Kraemer, B M Kalehzan, A F Schatzberg.   

Abstract

BACKGROUND: Considerable research has been devoted to the hypothalamic-pituitary-adrenal (HPA) axis in depression, but relatively little attention has been given to intensive monitoring of hormone secretion over time. Such research is potentially important because the HPA axis has prominent circadian and ultradian periodicity. Comparison of depressed patients with and without psychotic features is also important because HPA axis abnormalities may be especially pronounced in psychotic depressed patients.
METHODS: Eleven patients with psychotic major depression (PMD patients), 38 patients with nonpsychotic major depression (NPMD patients), and 33 healthy control subjects, all drug free, were studied. Patients with PMD and NPMD were outpatients recruited primarily by advertisement. Subjects were admitted to a General Clinical Research Center and had blood drawn through an intravenous line for determination of cortisol and corticotropin (ACTH) levels every hour for 24 hours.
RESULTS: Among NPMD patients, the 24-hour cortisol amplitude was significantly (P =.02) reduced in comparison with control subjects, while ACTH indices did not differ between NPMD patients and the control group. Among PMD patients, the ACTH 24-hour mean was significantly (P =.03) increased compared with controls, while PMD patients and the control group did not differ significantly in cortisol indices.
CONCLUSION: In the population studied, PMD and NPMD patients have distinct profiles of HPA axis dysregulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920463     DOI: 10.1001/archpsyc.57.8.755

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  44 in total

1.  Heightening of the stress response during the first weeks after a mild traumatic brain injury.

Authors:  G S Griesbach; D A Hovda; D L Tio; A N Taylor
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

2.  Central serotonin transporter levels are associated with stress hormone response and anxiety.

Authors:  Matthias Reimold; Astrid Knobel; Michael A Rapp; Anil Batra; Klaus Wiedemann; Andreas Ströhle; Anke Zimmer; Peter Schönknecht; Michael N Smolka; Daniel R Weinberger; David Goldman; Hans-Jürgen Machulla; Roland Bares; Andreas Heinz
Journal:  Psychopharmacology (Berl)       Date:  2010-06-29       Impact factor: 4.530

3.  The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

Authors:  Anna Lembke; Rowena Gomez; Lakshika Tenakoon; Jennifer Keller; Gregory Cohen; Gordon H Williams; Fredric B Kraemer; Alan F Schatzberg
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

Review 4.  Psychotic major depression: a benefit-risk assessment of treatment options.

Authors:  Audrey R Tyrka; Lawrence H Price; Marcelo F Mello; Andrea F Mello; Linda L Carpenter
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  Increased salivary cortisol after waking in depression.

Authors:  Zubin Bhagwagar; Sepehr Hafizi; Philip J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

6.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

7.  Effects of stressor controllability on diurnal physiological rhythms.

Authors:  Robert S Thompson; John P Christianson; Thomas M Maslanik; Steve F Maier; Benjamin N Greenwood; Monika Fleshner
Journal:  Physiol Behav       Date:  2013-02-27

Review 8.  [Childhood maltreatment and adult psychopathology: pathways to hypothalamic-pituitary-adrenal axis dysfunction].

Authors:  Marcelo F Mello; Alvaro A Faria; Andrea F Mello; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Braz J Psychiatry       Date:  2009-10       Impact factor: 2.697

9.  Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease.

Authors:  Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Steven Thomson; Paul I Oh; Stan Van Uum; Gideon Koren; Krista L Lanctôt
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

10.  Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study.

Authors:  Christian Otte; Charles R Marmar; Sharon S Pipkin; Rudolf Moos; Warren S Browner; Mary A Whooley
Journal:  Biol Psychiatry       Date:  2004-08-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.